A case of Corynebacterium pseudodiphtheriticum nosocomial pneumonia.
On April 1, 1998, a 68-year-old woman was admitted to the intensive care unit for acute respiratory distress. She had a 14-month history of amyotrophic lateral sclerosis. Three weeks before admission, she had been hospitalized for Staphylococcus aureus pneumonia and had recovered after treatment with amoxicillin and clavulanic acid plus ciprofioxacin. At the time of admission, the patient had a temperature of 38 [degrees] C. Systolic blood pressure was 120 mm Hg. Ventilation was spontaneous, with respirations 24 per minute; pulmonary sibilants were noted. Respiratory acidosis was also identified, with a pH of 7.35, SaO2 92%, PaO2 60 mm Hg, and PaCO2 60 mm Hg. Laboratory data included 18,000 leukocytes per ml (90% polymorpho-nuclear cells) and a serum fibrin level of 7 g/L. A chest X-ray showed pneumopathy of the lower segment of the right lung, which was compatible with the diagnosis of inhalation pneumopathy. On day 2 of admission, the patient's temperature was 39 [degrees] C, and she had paresis of the vocal cords. After C. pseudodiphtheriticum infection was diagnosed, treatment with intravenous cloxacillin (1 g 3 times/day) and amoxicillin plus clavulanic acid (1 g 3 times/day) was started. On day 3 after admission, the patient's breathing worsened, a radiograph showed bilateral pneumopathy, and she was intubated for mechanical ventilation. Two days later, her breathing improved, and a second bronchic aspiration was sterile. The patient eventually died of unrelated complications.
Direct microscopy examination of a Gram-stained bronchial aspiration sample showed numerous polymorphonuclear cells and gram-positive bacilli in parallel rows, which did not show pleomorphism. After 48 hours of incubation at 37 [degrees] C, [10.sup.6] colony-forming units/ml of a coryneform bacillus further identified as C. pseudodiphtheriticum grew in pure culture on blood agar gelose (BioMerieux, La Balme les Grottes, France) under a 5% [CO.sub.2] atmosphere and did not produce hemolysis. The test for catalase was positive, and the following biochemical characteristics were obtained by using a commercial identification strip (ApiCoryne, BioMerieux): absence of carbohydrate fermentation, urea hydrolysis, and nitrate reduction compatible with C. pseudodiphtheriticum. Minimum inhibitory concentrations (disk diffusion method) were 2 mg/L for amoxicillin, 2 mg/L for cefalotin, 0.09 mg/L for doxycycline, 0.03 mg/L for gentamicin, [is less than] 4 mg/L for vancomycin, 16 mg/L for erythromycin, and 20 mg/L for trimethoprim-sulfamethoxazole. Identification was confirmed by analysis of the cell-wall fatty acid profile by the Sherlock system, by the trypticase soy broth agar database 3.9 (MIDI Inc., Newark, DE), and by 16S rRNA sequence analysis under previously described conditions (2). The 16S rRNA gene sequence was compared with all eubacterial 16S rRNA sequences available in the GenBank database by using the multisequence comparison Advanced Blast NCBI. The sequence had a 99% similarity to that of C. pseudodiphtheriticum (1039/1047 base pairs).
Eighty-nine cases of infection possibly caused by C. pseudodiphtheriticum have been identified in the last 57 years. Of these, 57 (62.9%) were upper respiratory infections, which included rhinosinusitis, tracheitis, tracheobronchitis, and bronchitis; 19 (21.3%) were pneumonia (3-7). Ten (11.2%) cases of endocarditis were reported (8); there was also one case each of urinary tract malakoplakia after renal transplantation (9), lung abcess (10), diskitis (11), and lymphadenitis (12).
Unlike C. diphtheriae, C. pseudodiphtheriticum is a commensal bacterium that does not produce toxins and needs predisposing factors to become a pathogen causing pneumonia. Of patients with hospital-acquired C. pseudodiphtheriticum upper respiratory tract infections and pneumonia (7 of 26 upper respiratory tract infections and 2 of 14 cases of pneumonia reported in the early 1990s), all had underlying pathologic features. Predisposing factors were as follows: 33.7% had lung and tracheobronchial diseases, including chronic obstructive pulmonary disease, angina (5), chronic emphysema, asthma, and bronchitis (6); 32.5% had congestive heart failure (5). Of those with immunodepression, 5% had AIDS, 7.2% had undergone chemotherapy or prolonged steroid use; and 18.2% had other pathologic features, disseminated intravascular coagulation (6), chronic renal failure, diabetes mellitus (5), and connective tissue disease (5,6).
The first source of pneumonia is usually inhalation, as was the case for our patient, who had paresis of the vocal cords. She was not immunosuppressed but was debilitated by amyotrophic lateral sclerosis. The second factor is often an endotracheal intubation, as reported in a previously healthy 29-year-old trauma victim who contracted pneumonia due to C. pseudodiphtheriticum after 7 days of intubation (7). An increase in cases reported from 1932 to 1998 indicates the emergence of infections due to C. pseudodiphtheriticum. Thirty-four cases were reported from 1932 to 1989 (57 years), and 55 cases were reported from 1990 to 1998 (8 years). Reasons for the emergence of C. pseudodiphtheriticum infections may include confusion between C. diphtheriae and C. pseudodiphtheriticum infections. For example, two cases of C. pseudodiphtheriticum exudative upper respiratory tract infections with a pseudomembrane were first diagnosed as respiratory diphtheria. In the first case, C. pseudodiphtheriticum was isolated from a 32-year-old Uzbek man who had a severe sore throat and dysphagia lasting 2 days (3). In a second case, a 4-year-old girl had exudative pharyngitis with a pseudomembrane, which was possibly caused by C. pseudodiphtheriticum (4). The availability of commercial strips for the identification of C. pseudodiphtheriticum and 16S rRNA sequencing eliminates such confusion.
(1.) Brown AE. Other Corynebacteria and Rhodococcus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995. p. 1874.
(2.) Weisburg WC, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991;173:697-703.
(3.) Santos MR, Ghandi S, Vogler M, Hanna BA, Holzman RS. Suspected diphtheria in a Uzbek national; isolation of C. pseudodiphtheriticum resulted in a false positive presumptive diagnosis. Clin Infect Dis 1996;22:735.
(4.) Izurieta HS, Strebel PM, Youngblood T, Hollis DG, Popovic T. Exudative pharyngitidis possibly due to C. pseudodiphtheriticum, a new challenge in the differential diagnosis of diphtheria. Emerg Infect Dis 1997;3:65-8.
(5.) Manzella JP, Kellog JA, Parsey KS. Corynebacterium pseudodiphtheriticum: a respiratory tract pathogen in adults. Clin Infect Dis 1995;20:37-40.
(6.) Ahmed K, Kawakami K. Corynebacterium pseudodiphtheriticum: a respiratory tract pathogen. Clin Infect Dis 1995;20:41-6.
(7.) Miller RA, Rompalo A, Coyle MB. Corynebacterium pseudodiphtheriticum pneumonia in an immunologically intact host. Diagn Microbiol Infect Dis 1986;4:165-71.
(8.) Wilson ME, Shapiro DS. Native valve endocarditis due to Corynebacterium pseudodiphtheriticum. Clin Infect Dis 1992;15:1059-60.
(9.) Nathan AW, Turner DR, Aubrey C, Cameron JS, Williams DJ, Ogg CS, et al. Corynebacterium hofmannii infection after renal transplantation. Clin Nephrol 1982;17:315-8.
(10.) Andavolu RH, Venkita J, Lue Y, McLean T. Lung abscess involving Corynebacterium pseudodiphtheriticum in a patient with AIDS-related complex. New York State Journal of Medicine 1986;86:594-6.
(11.) Wright ED, Richards AJ, Edje AJ. Discitis caused by Corynebacterium pseudodiphtheriticum following ear, nose and throat surgery. Br J Rheumatol 1995;34:585-6.
(12.) LaRocco M, Robinson C, Robinson A. Corynebacterium pseudodiphtheriticum associated with suppurative lymphadenitis. European Journal of Clinical Microbiology 1987;6:79.
Cecile Martaresche, Pierre-Edouard Fournier, Veronique Jacomo, Marc Gainnier, Alain Boussuge, and Michel Drancourt
Hopital Salvator, Assistance Publique-Hopitaux de Marseille, Marseille, France
|Printer friendly Cite/link Email Feedback|
|Publication:||Emerging Infectious Diseases|
|Article Type:||Brief Article|
|Date:||Sep 1, 1999|
|Previous Article:||Human and animal epidemic of Yersinia enterocolitica 0:9, 1989-1997, Auvergne, France.|
|Next Article:||Family outbreak of Rickettsia conorii infection.|